You are here

Article info

Article menu
Download PDFPDF
Community child health, public health, and epidemiology
Should recombinant human growth hormone therapy be used in short small for gestational age children?

Authors

  • L B Johnston Paediatric Endocrine Section, Department of Endocrinology, William Harvey Research Institute, Barts and the London Queen Mary School of Medicine, London, UK PubMed articlesGoogle scholar articles
  • M O Savage Paediatric Endocrine Section, Department of Endocrinology, William Harvey Research Institute, Barts and the London Queen Mary School of Medicine, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to:
    Dr L B Johnston
    Senior Lecturer Honorary Consultant, Paediatric Endocrinology, St Bartholomew’s Hospital, London EC1A 7BE, UK; l.b.Johnstonqmul.ac.uk
View Full Text

Citation

Johnston LB, Savage MO
Should recombinant human growth hormone therapy be used in short small for gestational age children?
Archives of Disease in Childhood 2004;89:740-744.

Publication history

  • Accepted December 1, 2003
  • First published July 21, 2004.
Online issue publication 
January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright 2004 Archives of Disease in Childhood